
European Journal of Medicinal Chemistry
Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4
2025
For over a century, the Institut Pasteur has been at the forefront of the battle against infectious disease. Over the years, it has been responsible for breakthrough discoveries that have enabled medical science to control such virulent diseases.